siRNA therapy lowers triglycerides in clients with unusual health condition

.RESEARCH STUDY FEATURE.19 September 2024.

Plozasiran lessened triglyceride amounts by 80% as well as reduced the danger of pancreatitis in people along with chronic chylomicronemia, along with or without a genetic medical diagnosis.